Internal Medicine Doctors in Anthem, AZ Accepting Medicare

7 Internal Medicine doctors found. Showing 1 - 7

Joan Frances C Chua, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3655 W Anthem Way, Ste A-109; Pmb 313, Anthem, AZ 85086 Phone: 623-879-5288

Dustin Ray Everett, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3655 W Anthem Way, Suite A109 Pmb 313, Anthem, AZ 85086 Phone: 623-505-9880    Fax: 623-505-9880

Dr. Lucia Soto, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3655 W Anthem Way, Suite #a109 Pmb 313, Anthem, AZ 86086 Phone: 623-505-9880

Dr. John Boccia, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 40417 N Capra Way, Anthem, AZ 85086 Phone: 623-551-9478    Fax: 623-551-9479

Linda Brown, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3655 W Anthem Way Ste A109, Anthem, AZ 85086 Phone: 623-505-9880    Fax: 623-505-9880

Dr. Nisarg Sheth, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3655 W Anthem Way, Suite A109 Pmb 313, Anthem, AZ 85086 Phone: 623-505-9880

Nirmalji Odedra, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3655 W. Anthem Wy Ste A-109 Pmb313, Anthem, AZ 85086 Phone: 623-505-4479

News Archive

Early life sun exposure linked to melanomas with BRAF gene mutations

Skin cancers often contain different gene mutations, but just how these mutations contribute to the cause of melanomas has been a mystery.

Discovery of gene associated with narcolepsy

Scientists funded by the National Institutes of Health have identified a gene associated with narcolepsy, a disorder that causes disabling daytime sleepiness, sleep attacks, irresistible bouts of sleep that can strike at any time, and disturbed sleep at night. The gene has a known role in the immune system, which strongly suggests that autoimmunity, in which the immune system turns against the body's own tissues, plays an important role in the disorder.

EMA grants Orphan Drug Designation to Ceptaris' chlormethine gel for treatment of CTCL

Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Ceptaris' investigational drug, chlormethine gel, for the treatment of Cutaneous T-Cell Lymphoma.

New study helps policymakers prepare challenges associated with aging population

The fact that people are living longer lives represents one of the crowning achievements of the last century, but also requires careful planning on the part of governments.

Read more Medical News

› Verified 9 days ago